WO2010062783A2 - Polymer compositions of dihydroxyacetone and uses thereof - Google Patents

Polymer compositions of dihydroxyacetone and uses thereof Download PDF

Info

Publication number
WO2010062783A2
WO2010062783A2 PCT/US2009/063177 US2009063177W WO2010062783A2 WO 2010062783 A2 WO2010062783 A2 WO 2010062783A2 US 2009063177 W US2009063177 W US 2009063177W WO 2010062783 A2 WO2010062783 A2 WO 2010062783A2
Authority
WO
WIPO (PCT)
Prior art keywords
copolymer
pdha
peg
block
nitrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2009/063177
Other languages
English (en)
French (fr)
Other versions
WO2010062783A3 (en
Inventor
David Putnam
Peter Zaweneh
Jason Spector
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cornell University
Original Assignee
Cornell University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cornell University filed Critical Cornell University
Priority to JP2011534893A priority Critical patent/JP5788326B2/ja
Priority to EP09829696.5A priority patent/EP2362788B1/en
Priority to US13/127,464 priority patent/US8916143B2/en
Priority to BRPI0921791A priority patent/BRPI0921791B1/pt
Priority to CN200980152056.6A priority patent/CN102264399B/zh
Publication of WO2010062783A2 publication Critical patent/WO2010062783A2/en
Publication of WO2010062783A3 publication Critical patent/WO2010062783A3/en
Anticipated expiration legal-status Critical
Priority to US14/548,899 priority patent/US9629870B2/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0019—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/008—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G64/00—Macromolecular compounds obtained by reactions forming a carbonic ester link in the main chain of the macromolecule
    • C08G64/42—Chemical after-treatment

Definitions

  • the present disclosure provides, among other things, new surgical biomaterials with adjustable physiochemical properties that are biocompatible, easy to handle and apply, and useful for treating postoperative conditions and/or complications.
  • Such materials include copolymers whose physical and rheological properties can be fine-tuned by adjusting the length of its constituting blocks.
  • provided surgical biomaterials are useful in treating seromas, tissue adhesion, and/or bleeding.
  • a provided copolymer has a relaxation time of about 30 to about 1000 seconds. In certain embodiments, a provided copolymer has a relaxation time of about 100 to about 500 seconds. In certain embodiments, a provided copolymer has a relaxation time of about 200 to about 500 seconds. In certain embodiments, a provided copolymer has a relaxation time of about 200 to about 400 seconds. In certain embodiments, a provided copolymer has a relaxation time of about 200 to about 350 seconds. In certain embodiments, a provided copolymer has a relaxation time of about 225 to about 275 seconds. In certain embodiments, a provided copolymer has a relaxation time of about 250 seconds.
  • R , R , n, and m is as defined above and described in classes and subclasses herein;
  • R is R 5 . In some embodiments, R is -OR 5 . In other embodiments, R is -N(R ) 2 . In some embodiments, R is -N(R ) 2 , wherein each R is independently an optionally substituted group selected from C 1-10 aliphatic or phenyl. In some embodiments, R 3 is -NH(CH 2 ) 4 CH(NH 2 )CO 2 H.
  • a provided pDHA copolymer comprises a repeating subunit:
  • the present disclosure provides a method of treatment comprising administering a material comprising a poly-dihydroxyacetone (pDHA) copolymer at or near a wound bed or surgical site of a patient.
  • the present disclosure provides a method for the prevention or treatment of seromas, the method comprising the step of: administering a material comprising a poly- dihydroxyacetone (pDHA) copolymer at or near a wound bed or surgical site.
  • the wound bed or surgical site is in the abdomen.
  • Triethylamine, tetrahydrofuran (THF), dichloromethane (CH 2 Cl 2 ), diethyl ether, methanol, toluene, and TFA were purchased from VWR (West Chester, PA) and used as received.
  • Syringes and PBS (pH 7.4) were purchased from Fisher Scientific.
  • Collagen was purchased from MP Biomedicals.
  • Table 2 Summary of selected MPEG-pDHA gel swelling measurements, cross link density, and chain relaxation times following shear. Increasing the pDHA chain length reduces the extent of swelling and increases the hydrogel cross link density and relaxation time.

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Materials Engineering (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Diabetes (AREA)
  • Surgery (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Surgical Instruments (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Medicinal Preparation (AREA)
  • Prostheses (AREA)
PCT/US2009/063177 2008-11-03 2009-11-03 Polymer compositions of dihydroxyacetone and uses thereof Ceased WO2010062783A2 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
JP2011534893A JP5788326B2 (ja) 2008-11-03 2009-11-03 ジヒドロキシアセトンのポリマー組成物およびその使用
EP09829696.5A EP2362788B1 (en) 2008-11-03 2009-11-03 Polymer compositions of dihydroxyacetone and uses thereof
US13/127,464 US8916143B2 (en) 2008-11-03 2009-11-03 Polymer compositions of dihydroxyacetone and uses thereof
BRPI0921791A BRPI0921791B1 (pt) 2008-11-03 2009-11-03 uso de um material que compreende copolímero de poli(etilenoglicol)/polidiidroxiacetona (peg-pdha) na fabricação de medicamentos
CN200980152056.6A CN102264399B (zh) 2008-11-03 2009-11-03 二羟基丙酮的聚合物组合物和其用途
US14/548,899 US9629870B2 (en) 2008-11-03 2014-11-20 Polymer compositions of dihydroxyacetone and uses thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11073408P 2008-11-03 2008-11-03
US61/110,734 2008-11-03

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US11073408P Substitution 2008-11-03 2008-11-03

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US13/127,464 A-371-Of-International US8916143B2 (en) 2008-11-03 2009-11-03 Polymer compositions of dihydroxyacetone and uses thereof
US14/548,899 Division US9629870B2 (en) 2008-11-03 2014-11-20 Polymer compositions of dihydroxyacetone and uses thereof

Publications (2)

Publication Number Publication Date
WO2010062783A2 true WO2010062783A2 (en) 2010-06-03
WO2010062783A3 WO2010062783A3 (en) 2010-07-22

Family

ID=42226353

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2009/063177 Ceased WO2010062783A2 (en) 2008-11-03 2009-11-03 Polymer compositions of dihydroxyacetone and uses thereof

Country Status (6)

Country Link
US (2) US8916143B2 (cg-RX-API-DMAC7.html)
EP (1) EP2362788B1 (cg-RX-API-DMAC7.html)
JP (1) JP5788326B2 (cg-RX-API-DMAC7.html)
CN (2) CN104774326B (cg-RX-API-DMAC7.html)
BR (1) BRPI0921791B1 (cg-RX-API-DMAC7.html)
WO (1) WO2010062783A2 (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8383161B2 (en) 2009-12-15 2013-02-26 Incept, Llc Radioopaque covalently crosslinked hydrogel particle implants

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5788326B2 (ja) 2008-11-03 2015-09-30 コーネル ユニバーシティー ジヒドロキシアセトンのポリマー組成物およびその使用
US10300026B2 (en) 2015-08-24 2019-05-28 Shanxi Yabao Health Products Co., Ltd. Use of dihydroxyacetone in preparation of anti-cancer medicaments
EP3439620B1 (en) * 2016-04-07 2020-12-16 Cornell University Polymeric dha-containing biodegradable compositions and surgical barrier devices made thereof
US10590257B2 (en) 2016-09-26 2020-03-17 The Board Of Trustees Of The Leland Stanford Junior University Biomimetic, moldable, self-assembled cellulose silica-based trimeric hydrogels and their use as viscosity modifying carriers in industrial applications
US11975123B2 (en) 2018-04-02 2024-05-07 The Board Of Trustees Of The Leland Stanford Junior University Adhesion prevention with shear-thinning polymeric hydrogels
US11969526B2 (en) 2017-04-03 2024-04-30 The Board Of Trustees Of The Leland Stanford Junior University Adhesion prevention with shear-thinning polymeric hydrogels
US12599706B2 (en) 2017-04-03 2026-04-14 The Board Of Trustees Of The Leland Stanford Junior University Adhesion prevention with shear-thinning polymeric hydrogels
CN107141464B (zh) * 2017-05-14 2019-02-19 辽宁大学 一种通过希夫碱载药的两亲性聚碳酸酯聚乙二醇聚合物及其制备方法和应用
EP3860613B1 (en) 2018-10-01 2025-09-10 The Board of Trustees of the Leland Stanford Junior University Injectable hydrogels for controlled release of immunomodulatory compounds

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4049795A (en) * 1971-05-14 1977-09-20 Centre D'etudes Experimentales Et Cliniques De Physio Biologie De Pharmacologie Et D'eutonologie Treatment of hemorrhagic shock
EP0884045A1 (en) * 1997-06-06 1998-12-16 Pfizer Products Inc. Self-tanning dihydroxyacetone formulations having improved stability and providing enhanced delivery
US7659420B2 (en) * 2004-05-05 2010-02-09 Cornell Research Foundation, Inc Dihydroxyacetone-based polymers
US7910135B2 (en) * 2006-10-13 2011-03-22 Uluru Inc. Hydrogel wound dressing and biomaterials formed in situ and their uses
WO2008105178A1 (ja) * 2007-02-28 2008-09-04 National University Corporation Hokkaido University リポソーム用生体成分抵抗性増強剤及びこれにより修飾されたリポソーム
JP5788326B2 (ja) 2008-11-03 2015-09-30 コーネル ユニバーシティー ジヒドロキシアセトンのポリマー組成物およびその使用

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of EP2362788A4 *

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8383161B2 (en) 2009-12-15 2013-02-26 Incept, Llc Radioopaque covalently crosslinked hydrogel particle implants
US8852646B2 (en) 2009-12-15 2014-10-07 Incept, Llc Particulate implants and biodegradable fiducial markers
US9308283B2 (en) 2009-12-15 2016-04-12 Incept, Llc Implants and biodegradable fiducial markers
US9669117B2 (en) 2009-12-15 2017-06-06 Incept, Llc Implants and biodegradable tissue markers
US10272164B2 (en) 2009-12-15 2019-04-30 Incept, Llc Implants and biodegradable tissue markers
US10786581B2 (en) 2009-12-15 2020-09-29 Incept, Llc Implants and biodegradable tissue markers
US11083802B2 (en) 2009-12-15 2021-08-10 Incept, Llc Echolucent implant compositions and methods
US11154624B2 (en) 2009-12-15 2021-10-26 Incept, Llc Echolucent implant compositions and methods
US11160883B2 (en) 2009-12-15 2021-11-02 Incept, Llc Echolucent implant composition and methods
US11786612B2 (en) 2009-12-15 2023-10-17 Incept, Llc Implant and biodegradable tissue marker compositions and methods
US12622982B2 (en) 2009-12-15 2026-05-12 Incept, Llc Implants and biodegradable tissue markers

Also Published As

Publication number Publication date
US8916143B2 (en) 2014-12-23
EP2362788A2 (en) 2011-09-07
US20110212049A1 (en) 2011-09-01
CN102264399A (zh) 2011-11-30
CN104774326A (zh) 2015-07-15
CN104774326B (zh) 2017-04-12
EP2362788B1 (en) 2016-06-01
EP2362788A4 (en) 2013-04-03
JP2012508173A (ja) 2012-04-05
WO2010062783A3 (en) 2010-07-22
CN102264399B (zh) 2015-03-25
BRPI0921791B1 (pt) 2018-10-30
US20150079019A1 (en) 2015-03-19
US9629870B2 (en) 2017-04-25
JP5788326B2 (ja) 2015-09-30
BRPI0921791A2 (pt) 2015-08-25

Similar Documents

Publication Publication Date Title
US9629870B2 (en) Polymer compositions of dihydroxyacetone and uses thereof
Yang et al. Injectable adaptive self-healing hyaluronic acid/poly (γ-glutamic acid) hydrogel for cutaneous wound healing
Uhlig et al. Suprathel®—an innovative, resorbable skin substitute for the treatment of burn victims
JP4863550B2 (ja) マロン酸メチリデンベース傷縫合材料
Zhang et al. A transparent sericin-polyacrylamide interpenetrating network hydrogel as visualized dressing material
Zawaneh et al. Design of an injectable synthetic and biodegradable surgical biomaterial
KR101649792B1 (ko) 비압박 지혈용 고분자 폼 제조용 조성물, 이를 이용한 비압박 지혈용 고분자 폼의 제조방법 및 비압박 지혈 팩킹용 고분자 폼
CN103083713A (zh) 一种无菌聚合创面覆盖物敷料
KR101845885B1 (ko) 입자형 무세포 진피 기반의 온도감응성 유착방지 조성물의 제조방법
Huang et al. ROS-responsive sprayable hydrogel as ROS scavenger and GATA6+ macrophages trap for the prevention of postoperative abdominal adhesions
Yuan et al. 5-Fluorouracil loaded thermosensitive PLGA–PEG–PLGA hydrogels for the prevention of postoperative tendon adhesion
US20130252921A1 (en) Adhesion barrier containing hyaluronic acids and l-arginine
KR20140100245A (ko) 고분자 조성물 및 이로부터 탄성 창상피복재의 제조방법
AU2003221916A1 (en) Tissue defect dressings comprising a keratin network
CN112851978A (zh) 可自愈合的强韧型脂肽表面活性素水凝胶及其制备方法
CN103159967A (zh) 一种具有自抗炎功能的胶原基海绵伤口敷料的制备方法
Korley et al. One-step synthesis, biodegradation and biocompatibility of polyesters based on the metabolic synthon, dihydroxyacetone
EP2203500B1 (en) Absorbable polymer formulations
KR101180286B1 (ko) 히알루론산 에폭사이드 유도체 하이드로겔을 포함하는 유착방지제 및 이의 제조 방법
CN114514267A (zh) 包含透明质酸和聚乙二醇的生物相容性水凝胶
CN105944138A (zh) 一种可生物降解医用聚氨酯壳聚糖复合止血绵的制备
EP1216066A1 (en) Compositions for the treatment of wound contracture
Devi et al. Exploring bioactive tragacanth gum for developing nerve regenerating agent imprinted hydrogels for brain drug delivery
Lee et al. Carboxymethyl cellulose/polyethylene glycol superabsorbent hydrogel crosslinked with citric acid
KR102103180B1 (ko) 히알루론산유도체, 플루란 및 카르복시메틸 셀룰로오스를 포함하는 유착방지용 조성물 및 이의 제조방법

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200980152056.6

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09829696

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 2011534893

Country of ref document: JP

NENP Non-entry into the national phase in:

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 13127464

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2009829696

Country of ref document: EP

ENP Entry into the national phase in:

Ref document number: PI0921791

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20110503